Pioglitazone for Oral Premalignant Lesions

Clinical trial NCT00951379 · TERMINATED

Trial details

NCT number: NCT00951379
Sponsor: National Cancer Institute (NCI)
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Oral Leukoplakia

Start date: 2010-02-01
Primary completion: 2014-03-01
Enrollment: 52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.